Three major neuronal mitogens that contribute to the promotion of glioma progression have been studied: neuronal surface protein neuroligin3 (NLGN3), brain-derived neurotrophic factor (BDNF) and transmembrane protein semaphorin-4F (SEMA4F). The gene discussed is SEMA4F; the disease is central nervous system cancer.